Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)

Exclusion Criteria

• •Pregnancy or lactation
• •Specific contraindications to BEACOPPesc therapy, including:
• •Poorly controlled diabetes mellitus
• •HIV infection,
• •Chronic active hepatitis B and/or hepatitis C
• •Concomitant or previous malignancies with the exception of basal cell skin tumors, adequately treated carcinoma in situ of the cervix and any cancer that has been in complete remission for \>5 years
• •Psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial